type
status
date
slug
summary
tags
category
icon
password
Text
MICU藥品配製 2018/02/15 李依玟藥師整理
配製法 | 濃度 | 單位 | 給藥 | Dose | 60kg/hr | 70kg/hr | 80kg/hr | |
Amiodarone 150mg/3mL/Amp | 6# in D5W 500 ml | 1.74 | mg/ml | *前6 hrs: 34 cc/hr, 後18hrs: 17 cc/hr | ㅤ | ㅤ | ㅤ | |
Atracurium 25mg/2.5mL/Amp | Pure | 10 | mg/ml | CVP | Initial bolus of 0.4 to 0.5 mg/kg,
→ 0.24 to 1.2 mg/kg/hour | 2.4-3 ml | 2.8-3.5 ml | 3.2-4 ml |
ㅤ | ㅤ | ㅤ | ㅤ | ㅤ | ㅤ | 1.4-7.2 ml | 1.6-8.4 ml | 1.9-9.6 ml |
Cisatracurium 10 mg/5 ml/Amp | Pure | 2 | mg/ml | CVP | Initial bolus of 0.1 to 0.2 mg/kg
→ 0.06 to 0.18 mg/kg/hour | 3-6 ml | 3.5-7 ml | 4-8 ml |
ㅤ | ㅤ | ㅤ | ㅤ | ㅤ | ㅤ | 2-6 ml | 2.1-6.3 ml | 2.4-7.2 ml |
Dexmedetomidine 200mcg/2mL/Vial | 1# + NS 48 ml | 4 | mcg/ml | Initial 0.5 to 1 mcg/kg
→ 0.2 to 0.7 mcg/kg/hour [4] | 7.5-15 ml
3-10 ml | 8.75-17.5 ml
3.5-12.25 ml | 10-20 ml
4-14 ml | |
Dobutamine 250 mg/20 ml/Vial | 2# in NS 250 ml | 2000 | mcg/ml | CVP | 120-1200 mcg/kg/hour | 3.6-36 ml | 4.2-42 ml | 4.8-48 ml |
ㅤ | 4# in NS 250 ml | 4000 | ㅤ | ㅤ | ㅤ | 1.8-18ml | 2.1-21 ml | 2.4-24 ml |
Dopamine 200mg/5ml/Amp
| 2# in NS 250 ml | 1600
| mcg/ml | CVP | HR: 300 to 600 mcg/kg/hr
BP: >600 mcg/kg/hr | 11.25-22.5 ml
>22.5 ml | 13-26 ml
> 26 ml | 15-30 ml
> 30 ml |
ㅤ | 4# in NS 250 ml | 3200 | ㅤ | ㅤ | HR: 300 to 600 mcg/kg/hr
BP: >600 mcg/kg/hr | 6 -11 ml
>11 ml | 6.5-13 ml
> 13 ml | 7.5 - 15 ml
> 15 ml |
Epinephrine 1 mg/ml/Amp | 10# in NS 250 ml | 40 | mcg/ml | CVP | 6-30 mcg/kg/hr | 9 – 45 ml | 10.5-52 ml | 12-60 ml |
Fentanyl 0.05 mg/mL 10mL/Amp
Fentanyl 0.1 mg/2 ml/Amp | Pure | 50 | mcg/mL | 0.7 to 10 mcg/kg/hour [4] | 1 - 12 ml | 1-14 ml | 1-16 ml | |
Isoproterenol 0.2mg/mL/Amp | 10# in NS 250 ml | 8 | mcg/mL | CVP | Cardiogenic shock due to bradycardia:
120-1200 mcg/hr | 15-150 ml
| ㅤ | ㅤ |
Labetalol 25mg/5mL/Amp | 10# in NS 250 ml | 1 | mg/ml | Initial: 30 to 120 mg/hr | 30-120 ml | ㅤ | ㅤ | |
Lidocaine 2% 100mg/5mL/Amp | 10# in NS 250 ml | 4 | mg/ml | ㅤ | ㅤ | |||
Lorazepam 2 mg/ml/Amp | 1# + NS 1 ml | 1 | mg/ml | 0.01 -0.1 mg/kg/hour (Max: 10ml/hr)[4] | 0.6-6 ml | 0.7-7 ml | 0.8-8 ml | |
ㅤ | 10# in NS 250 ml | 0.08 | ㅤ | ㅤ | ㅤ | 7.5-75 ml | 8.75-87 ml | 10-100 ml |
Midazolam 15 mg/3ml/Amp | Pure | 5 | mg/ml | CVP | Sedation: 0.02 to 0.1 mg/kg/hour [4]
Status epilepticus:0.05 to 2 mg/kg/hr[5] | 0.24 -1.2 ml
0.6 – 24 ml | 0.28-1.4 ml
0.7 – 28 ml | 0.32-1.6 ml
0.8 - 32 ml |
ㅤ | 10# in NS 250 ml | 0.54 | ㅤ | ㅤ | 2.4 -12 ml
6 - 240 ml | 2.8-14 ml
7 - 280 ml | 3.2-16 ml
8 - 32 ml |
配製法 | 濃度 | 單位 | 給藥 | Dose | 60kg/hr | 70kg/hr | 80kg/hr | |
Morphine 10 mg/ml/Amp | 10# in NS 250 ml | 0.4 | mg/ml | Analgesia for MV: 0.07-0.5 mg/kg/hr[4]
| 10.5-75 ml | 12.25-87.5 ml | 14-100 ml | |
ㅤ | 10# in NS 100 ml | 1 | ㅤ | ㅤ | ㅤ | 4.2 -30 ml | 4.9-35 ml | 5.6-40 ml |
Nicardipine 10mg/10mL/Amp | 1# in 100 ml | 0.1 | mg/ml | CVP | Initial: 3-5 mg/hour (Max: 15 mg/hr)
**pure易造成靜脈炎(小心)** | 30-50 ml | ㅤ | ㅤ |
ㅤ | Pure | 1 | ㅤ | ㅤ | ㅤ | 3-5 ml | ㅤ | ㅤ |
Norepinephrine 4mg/4mL/Vial | 8# in D5W 500 ml
4# in D5W 250 ml
2# in D5W 125 ml | 60.15 | mcg/ml | CVP | Initial: 480-720 mcg/hr [1](Max: 1.8 mg/hr)[3]
Range: 1.8 -180 mcg/kg/hr [2] | 8-12 ml ( Max: 30 ml) | ㅤ | ㅤ |
ㅤ | ㅤ | ㅤ | ㅤ | ㅤ | ㅤ | 1.8-180 ml | 2.1-210 ml | 2.4-240 ml |
Propofol 200mg/20mL/Amp | Pure | 10 | mg/ml | CVP | Sedation: Initial: 0.3 mg/kg/hour
→ 0.3 to 3 mg/kg/hour[4]
Status epilepticus: 1.8 to 12 mg/kg/hour[5] | 1.8 ml | 2.1 ml | 2.4 ml |
ㅤ | ㅤ | ㅤ | ㅤ | ㅤ | ㅤ | 1.8-18 ml | 2.1-21 ml | 2.1-24 ml |
ㅤ | ㅤ | ㅤ | ㅤ | ㅤ | ㅤ | 10.8-72 ml | 12.6-84 ml | 14.4-96 ml |
Rocuronium 50mg/5mL/Vial | Pure | 10 | mg/ml | CVP | Initial bolus of 0.6 to 1 mg/kg
→ 0.48 to 0.72 mg/kg/hour | 3.6-6 ml | 4.2-7 ml | 4.8-8 ml |
ㅤ | ㅤ | ㅤ | ㅤ | ㅤ | ㅤ | 2.88-4.32 ml | 3.36-5 ml | 3.8-5.76ml |
Vasopressin 20 U/ml/Amp | 5# in NS 250 ml | 0.4 | unit/ml | CVP | 1.2-2.4 Unit/hr | 3-6 ml/hr | ㅤ | ㅤ |
Reference:
- Manufacturer: Product Information
- Steven M. Hollenberg, MD: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit. Care Med 2004 Vol. 32, No. 9
- Nina Vadiei: Impact of Norepinephrine Weight-Based Dosing Compared With Non–Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock. Annals of Pharmacotherapy 2016
- Juliana Barr, MD: Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit. Crit. Care Med 2013.
- Gretchen M. Brophy: Guidelines for the Evaluation and Management of Status Epilepticus. Neurocritical Care Society 2012